Criterios de Beers para identificar el consumo de medicación potencialmente inapropiada: adaptación para su aplicación en Argentina / Beers criteria to identify the consumption of potentially inappropriate medication: adaptation for its application inArgentina

Introducción. Los Criterios de Beers son los más utilizados para evaluar el uso de medicación potencialmente inapropiada en grandes poblaciones, pero no contemplan algunos medicamentos de uso frecuente fuera de los EE.UU. Objetivo. Realizar una adaptación al contexto de Argentina de los Criterios de Beers publicados en 2019. Métodos. Fue elaborada una lista preliminar de medicación potencialmente inapropiada adaptada a la comercialización local, que luego fue consensuada por un panel de expertos (método Delphi). Resultados. De los 112 medicamentos originales listados en la tabla dos de los Criterios de Beers (en forma individual o como grupo), fueron excluidos 36 por no estar disponibles el país y fueron sumados 23 que no se comercializan en los EE.UU. pero sí en Argentina. Luego de dos rondas y de consensuar la suma a esta lista de dos grupos farmacológicos(antimigrañosos y vasodilatadores periféricos), fue acordado el agregado de picosulfato, bisacodilo, senósidos y cáscara sagrada como medicación potencialmente inapropiada en el grupo de agentes contra el estreñimiento, la fluoxetina entre los inhibidores selectivos de la recaptación de serotonina y el Ginkgo biloba como droga contra la demencia. También hubo consenso en advertir el riesgo de hipotensión ortostática asociado a la tamsulosina, en aconsejar la consideración de la carga anticolinérgica total del esquema terapéutico administrado y en recomendar al paracetamol como primera línea de tratamiento del dolor, asociado o no a opioides. Conclusiones. Contar con una versión de los Criterios de Beers 2019 adaptada al contexto de Argentina contribuirá al desarrollo y monitoreo de intervenciones para prevenir y reducir el consumo de medicación potencialmente inapropiada. (AU)

Introduction.The Beers Criteria is the most widely used criteria to assess the use of potentially inappropriate medication in large populations, but they do not include some medications that are frequently used outside the United States. Objective.To make an adaptation of the Beers Criteria published in 2019 to the context of Argentina. Methods. A preliminary list of potentially inappropriate medication adapted to local market and practice was designed, which was then agreed upon by a panel of experts (Delphi method). Results. Of the 112 original drugs in the table 2 of the Beers Criteria (individually or as a group), 36 were excluded because they were not available in Argentina and 23 locally marketed drugs but not in the US were included. After two rounds and agreeing to add two additional pharmacological groups to this list (antimigraine and peripheral vasodilators), it was decided to add picosulfate, bisacodyl, sennosides and cascara sagrada as potentially inappropriate medication in the group of anti-constipation agents, fluoxetine among. the selective serotonin reup take inhibitors and Ginkgo biloba as an anti-dementia drug. There was also consensus in warning about the risk of orthostatic hypotension associated with tamsulosin,in advising consideration of the total anticholinergic load of the therapeutic regimen administered, and in recommending paracetamol as the first line of pain treatment, associated or not with opioids. Conclusions. Having a version of the Beers Criteria 2019 adapted to the Argentine context will contribute to the development and monitoring of interventions to prevent and reduce the consumption of potentially inappropriate medication. (AU)

Prevalence, types and severity of medication errors associated with the use of automated medication use systems in ambulatory and institutionalized care settings: A systematic review protocol.

The use of automated systems within the medication use process has significantly reduce the occurrence of medication errors and the associated clinical and financial burden. However, automated systems lull into a false sense of security and increase the risk of medication errors that are often associated with socio-technical interactions, automation bias, workarounds and overrides. The objective of the systematic review is to determine the prevalence, types and severity of medication errors that are associated the use of automated systems in ambulatory and institutionalized care settings. The search strategy will be guided by PRISMA framework. Selected databases and relevant gray literature were searched and screening was done independently by two researchers between 01 April and 29 June 2021. These covered all relevant articles published from the inception of the use of automation in the medication use process (2000) until 2020. De-duplication and screening of all studies were done independently by two researchers with a clear inclusion / exclusion criteria. Data extraction and synthesis are currently on going (started on 06 July 2021) and being conducted independently but the validity and completeness of the processes will be confirmed by the third researcher. The Cochrane Risk of Bias tool and the Hoy et al's quality assessment checklist will be used for the assessment of methodological bias while the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system will be used for the quality of evidence assessment. Detailed qualitative synthesis of key findings will be done with thematic and descriptive analyses. If the number and types of included studies permit, fixed or random effect model meta-analysis will be conducted based on the degree of homogeneity in the sampling frame used in the included studies. Heterogeneity will be assessed with I2 statistics and I2 > 50% will be considered a high statistical heterogeneity. The systematic review may provide new perspective especially from developing settings about the prevalence, types and severity of medication errors associated with the use of automated systems at all the stages of medication use process, and in all categories of patients. This may add to global knowledge in the research area. Systematic review registration: The systematic review was registered and published by PROSPERO (CRD42020212900).

Storage of Medications: A Survey of Families in the Pediatric Emergency Department.

OBJECTIVES: To evaluate caregivers' practice of prescription medication storage, particularly of opioid medications, as well as to provide educational materials to families about the opioid crisis. METHODS: Caregivers of patients in a pediatric emergency department were asked to participate in a survey about medication storage practices and beliefs, focusing on opioid medications. Data were collected through a survey documenting demographic data along with knowledge and behaviors of medication storage. Brief education about the US opioid crisis and safe storage was provided. RESULTS: In total, 233 families participated; 3 families declined; 11.5% of caregivers reported storing prescribed medications in a locked or latched place, although most store them "out of reach." Most believed their child or children's friends could not easily access their medications (81.8%). Families who did not keep their medications in locked or latched places had never thought about it (39.7%). In total, 33% of respondents were unaware of the opioid crisis; 87.4% of caregivers said they would use a medication lock box if given one. CONCLUSIONS: Many caregivers are not aware of the opioid crisis and do not keep opioid medications locked up. Half of the caregivers surveyed stated they "never thought about" locking up medications. Most parents would use a lock box if given to them. This opens the door to further study, education, and interventions.

Effect of a Multifaceted Clinical Pharmacist Intervention on Medication Safety After Hospitalization in Persons Prescribed High-risk Medications: A Randomized Clinical Trial.

Importance: The National Action Plan for Adverse Drug Event (ADE) Prevention identified 3 high-priority, high-risk drug classes as targets for reducing the risk of drug-related injuries: anticoagulants, diabetes agents, and opioids. Objective: To determine whether a multifaceted clinical pharmacist intervention improves medication safety for patients who are discharged from the hospital and prescribed medications within 1 or more of these high-risk drug classes. Design, Setting, and Participants: This randomized clinical trial was conducted at a large multidisciplinary group practice in Massachusetts and included patients 50 years or older who were discharged from the hospital and prescribed at least 1 high-risk medication. Participants were enrolled into the trial from June 2016 through September 2018. Interventions: The pharmacist-directed intervention included an in-home assessment by a clinical pharmacist, evidence-based educational resources, communication with the primary care team, and telephone follow-up. Participants in the control group were provided educational materials via mail. Main Outcomes and Measures: The study assessed 2 outcomes over a 45-day posthospital discharge period: (1) adverse drug-related incidents and (2) a subset defined as clinically important medication errors, which included preventable or ameliorable ADEs and potential ADEs (ie, medication-related errors that may not yet have caused injury to a patient, but have the potential to cause future harm if not addressed). Clinically important medication errors were the primary study outcome. Results: There were 361 participants (mean [SD] age, 68.7 [9.3] years; 177 women [49.0%]; 319 White [88.4%] and 8 Black individuals [2.2%]). Of these, 180 (49.9%) were randomly assigned to the intervention group and 181 (50.1%) to the control group. Among all participants, 100 (27.7%) experienced 1 or more adverse drug-related incidents, and 65 (18%) experienced 1 or more clinically important medication errors. There were 81 adverse drug-related incidents identified in the intervention group and 72 in the control group. There were 44 clinically important medication errors in the intervention group and 45 in the control group. The intervention did not significantly alter the per-patient rate of adverse drug-related incidents (unadjusted incidence rate ratio, 1.13; 95% CI, 0.83-1.56) or clinically important medication errors (unadjusted incidence rate ratio, 0.99; 95% CI, 0.65-1.49). Conclusions and Relevance: In this randomized clinical trial, there was not an observed lower rate of adverse drug-related incidents or clinically important medication errors during the posthospitalization period that was associated with a clinical pharmacist intervention. However, there were study recruitment challenges and lower than expected numbers of events among the study population. Trial Registration: ClinicalTrials.gov Identifier: NCT02781662.

Do Errorless Methods Improve Discharge Medication Instruction and Adherence?

PURPOSE AND DESIGN: Postdischarge adverse drug events are a national issue, and effective inpatient instruction may help. Therefore, this intervention study examined whether using errorless teaching/learning methods including pictorial medication cards (ETL + card) improved RN teaching and patient medication adherence among persons with cognitive challenges (PWCCs). METHODS: Convenience samples of RNs and PWCCs from a 24-bed rehabilitation unit provided baseline data. RNs implemented ETL + card, and postintervention data were collected. Adapted and investigator-designed instruments had preliminary reliability/validity. FINDINGS: Postintervention RNs demonstrated more teaching strategies (p = .003), and teaching satisfaction rose from 0% to 50%. Minutes per teaching interaction were unchanged (p > .05). Baseline patients filled a higher number (p = .02) but a lower percentage (67%) of their prescriptions than did postintervention patients (85%). Medication dose adherence scores were unchanged (p > .05). CONCLUSIONS: ETL + card improved RN teaching and possibly patient adherence. Further study is warranted. CLINICAL RELEVANCE: ETL + card may help PWCCs achieve safe medication self-management.

Improving medication safety practice at a community hospital: a focus on bar code medication administration scanning and pain reassessment.

INTRODUCTION: In the USA over 30% of medication errors occur at the point of administration. Among non-surgical patients in US hospitals exposed to opioids, 0.6% experience a severe opioid-related adverse event. In September 2018, Sierra View Medical Center identified two areas of opportunity for quality improvement: bedside bar code medication administration (BCMA) and pain reassessments. At baseline (April 2018 to September 2018) only 81% of medications were scanned prior to administration with pain reassessments completed only 41% of the time 1 hour postopioid administration. OBJECTIVE: To improve BCMA scanning rates (goal ≥95%) and pain reassessments within 1 hour postopioid administration (goal ≥90%). METHODS: Implementation methods included data transparency, weekly dashboards, education and plan-do-study-act (PDSA) cycles informed by feedback from key stakeholders. RESULTS: Following a series of PDSA cycle implementations, barcode medication administration (BCMA) scanning rates improved by 14% (from 81% to 95%) and pain reassessments improved by 50% (from 41% to 91%), sustained 17 months postproject implementation (October 2018 to February 2019). The number of adverse drug events (ADEs) related to administration errors decreased by 17% (estimated annual cost savings of $120 750-239 725 per year) and opioid-related ADEs decreased by 2.6% (estimated annual cost savings of $72 855-80 928 per year). CONCLUSION: Adopting John Kotter's model for change, developing performance dashboards and sustaining engagement among stakeholders on a weekly basis improved bar code medication scanning rates and pain reassessment compliance. The stakeholders created momentum for change in both practice and culture resulting in improved patient safety with a favourable financial impact.

Recomendaciones sobre los fármacos empleados en pacientes oncohematológicos afectos de COVID-19. Una aproximación a las interacciones farmacológicas entre el tratamiento sintomático y el tratamiento "anti-COVID-19" / Recommendations on the drugs used for oncohematological patients with COVID-19. An approach to drug-drug interactions between symptom treatment and anti-COVID-19 treatment

La pandemia por SARS-CoV-2 que expuso a nuestros pacientes a una importante carga sintomática hizo de los cuidados paliativos una herramienta necesaria para la atención de estos pacientes. Los fármacos empleados para contrarrestar el virus y los tratamientos para el control de síntomas tienen múltiples interacciones debido tanto al hepatotrofismo del virus como a las vías de metabolismo de los tratamientos. Con este artículo pretendemos compartir nuestra experiencia y algunas recomendaciones farmacológicas para minimizar potenciales interacciones y efectos secundarios de los tratamientos empleados. Queda mucho por investigar, pero creemos que compartiendo información entre centros podremos brindar el mejor abordaje multidisciplinar que merecen los pacientes

The SARS-CoV-2 pandemic that exposed our patients to a significant symptom burden made palliative care a necessary tool for the care of these patients. The drugs used to counteract the virus and the treatments used for the control of symptoms have multiple interactions due to both the hepatotrophism of the virus and the metabolism pathways of treatments. With this article we aim to share our experience and some pharmacological recommendations to minimize the potential interactions and side effects of treatments. Much remains to be investigated but we believe that by sharing information between centers we shall be able to provide the best multidisciplinary approach that patients deserve

Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project.

INTRODUCTION: Ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam and ceftolozane-tazobactam are novel antibiotics used to treat infections caused by multidrug-resistant pathogens (MDR). Their use should be supervised and monitored as part of an antimicrobial stewardship programme (ASP). Appropriate use of the new antibiotics will be improved by including consensual indications for their use in local antibiotic guidelines, together with educational interventions providing advice to prescribers to ensure that the recommendations are clearly understood. METHODS AND ANALYSIS: This study will be implemented in two phases. First, a preliminary historical cohort (2017-2019) of patients from 13 Andalusian hospitals treated with novel antibiotics will be analysed. Second, a quasiexperimental intervention study will be developed with an interrupted time-series analysis (2020-2021). The intervention will consist of an educational interview between prescribers and ASP leaders at each hospital to reinforce the proper use of novel antibiotics. The educational intervention will be based on a consensus guideline designed and disseminated by leaders after the retrospective cohort data have been analysed. The outcomes will be acceptance of the intervention and appropriateness of prescription. Incidence of infection and colonisation with MDR organisms as well as incidence of Clostridioides difficile infection will also be analysed. Changes in prescription quality between periods and the safety profile of the antibiotics in terms of mortality rate and readmissions will also be measured. ETHICS AND DISSEMINATION: Ethical approval will be obtained from the Andalusian Coordinating Institutional Review Board. The study is being conducted in compliance with the protocol and regulatory requirements consistent with International Council of Harmonisation E6 Good Clinical Practice and the ethical principles of the latest version of the Declaration of Helsinki. The results will be published in peer-reviewed journals and disseminated at national and international conferences. TRIAL REGISTRATION NUMBER: NCT03941951; Pre-results.

Self-Administration of Medication in Hospital: A Literature Review.

The idea of patients self-administering their medication in hospital is not new; it was first cited in literature in 1959. Up to date, there is a growing body of literature that recognizes the importance of this approach. In this current state of the literature, self-administration of medication in hospital is positioned in the context of the definition of health as proposed by Huber et al. and Orem's self-care deficit theory: first identify the concept of medication self-administration, as well as the prevalence, existing procedures, tools, and proven effects of interventions; then the findings should point the way forward for research, practice, and policy.

Role of nurses in medication management at the end of life: a qualitative interview study.

BACKGROUND: Patients in the last phase of their lives often use many medications. Physicians tend to lack awareness that reviewing the usefulness of medication at the end of patients' lives is important. The aim of this study is to gain insight into the perspectives of patients, informal caregivers, nurses and physicians on the role of nurses in medication management at the end of life. METHODS: Semi-structured interviews were conducted with patients in the last phase of their lives, in hospitals, hospices and at home; and with their informal caregivers, nurses and physicians. Data were qualitatively analyzed using the constant comparative method. RESULTS: Seventy-six interviews were conducted, with 17 patients, 12 informal caregivers, 15 nurses, 20 (trainee) medical specialists and 12 family physicians. Participants agreed that the role of the nurse in medication management includes: 1) informing, 2) supporting, 3) representing and 4) involving the patient, their informal caregivers and physicians in medication management. Nurses have a particular role in continuity of care and proximity to the patient. They are expected to contribute to a multidimensional assessment and approach, which is important for promoting patients' interest in medication management at the end of life. CONCLUSIONS: We found that nurses can and should play an important role in medication management at the end of life by informing, supporting, representing and involving all relevant parties. Physicians should appreciate nurses' input to optimize medication management in patients at the end of life. Health care professionals should recognize the role the nurses can have in promoting patients' interest in medication management at the end of life. Nurses should be reinforced by education and training to take up this role.

An exploration of the experiences of professionals supporting patients approaching the end of life in medicines management at home. A qualitative study.

BACKGROUND: The management of medicines towards the end of life can place increasing burdens and responsibilities on patients and families. This has received little attention yet it can be a source of great difficulty and distress patients and families. Dose administration aids can be useful for some patients but there is no evidence for their wide spread use or the implications for their use as patients become increasing unwell. The study aimed to explore how healthcare professionals describe the support they provide for patients to manage medications at home at end of life. METHODS: Qualitative interview study with thematic analysis. Participants were a purposive sample of 40 community healthcare professionals (including GPs, pharmacists, and specialist palliative care and community nurses) from across two English counties. RESULTS: Healthcare professionals reported a variety of ways in which they tried to support patients to take medications as prescribed. While the paper presents some solutions and strategies reported by professional respondents it was clear from both professional and patient/family caregiver accounts in the wider study that rather few professionals provided this kind of support. Standard solutions offered included: rationalising the number of medications; providing different formulations; explaining what medications were for and how best to take them. Dose administration aids were also regularly provided, and while useful for some, they posed a number of practical difficulties for palliative care. More challenging circumstances such as substance misuse and memory loss required more innovative strategies such as supporting ways to record medication taking; balancing restricted access to controlled drugs and appropriate pain management and supporting patient choice in medication use. CONCLUSIONS: The burdens and responsibilities of managing medicines at home for patients approaching the end of life has not been widely recognised or understood. This paper considers some of the strategies reported by professionals in the study, and points to the great potential for a more widely proactive stance in supporting patients and family carers to understand and take their medicines effectively. By adopting tailored, and sometimes, 'outside the box' thinking professionals can identify immediate, simple solutions to the problems patients and families experience with managing medicines.

Nursing students' perceptions of clinical learning opportunities and competence in administration of oral medication in the Western Cape.

BACKGROUND: Medication errors may result in patients' harm and even death. The improvement of nursing students' competence in the administration of medication through education and training can contribute to the reduction of medication errors. OBJECTIVES: This study aimed at describing the Bachelor of Nursing students' perceptions about clinical learning opportunities and competence in the administration of oral medication. METHOD: A quantitative descriptive design was employed. An all-inclusive sample of 176 nursing students registered at a university in the Western Cape, South Africa, in 2014 was considered for the study, of whom 125 students consented to participate and completed the questionnaires. Statistical Package for the Social Sciences (SPSS) version 22 was used for data analysis and descriptive statistics were conducted. RESULTS: The findings showed that a minority of students did not have opportunities to rotate in all specific types of wards. The findings indicated that a total of 92% (115) and 86.4% (108) of the 125 respondents were placed in medical and surgical wards, respectively, where they more likely had opportunities to practise the administration of oral medication. However, 59.2% (74) did not practise administration of oral medication on a daily basis. Only 19.2% (24) of respondents perceived themselves as competent in the administration of oral medication. CONCLUSION: The findings indicated that many students perceived their education and training as not providing sufficient learning opportunities to practise the administration of oral medication, whilst the majority of respondents perceived themselves as competent in some of the aspects related to the administration of oral medication, and very few perceived themselves as competent overall in the administration of oral medication.

Back to Basics: Medication Safety.

Perioperative nurses administer some medications but are primarily responsible for obtaining, preparing, and documenting medications. Unlike personnel in many other patient care areas, perioperative personnel may not have immediate access to a pharmacist; this lack of pharmacy support can complicate medication administration processes. A variety of medication errors occur in the perioperative setting and can negatively affect patients and personnel. Perioperative nurses should review regulatory information and professional organization guidance documents when they work with other health care team members to address medication safety issues. Some recommendations include submitting clear medication orders, using aseptic technique when transferring medications to the sterile field, and using standardized labeling. In addition, perioperative nurses should obtain only one patient's medications from a dispensing unit at a time and prepare one medication at a time. After reviewing this article and the supporting literature, perioperative nurses should have increased knowledge about medication safety.

Erros no preparo e na administração de medicamentos intravenosos / Errores en la preparación y administración de medicamentos intravenosos / Errors in the preparation and administration of intravenous drugs

Objetivo identificar os erros no preparo e na administração de medicamentos intravenosos. Método estudo observacional e descritivo realizado de 694 doses de medicamentos intravenosos realizadas pelos profissionais de enfermagem em pacientes adultos nas unidades de Emergência, Internamento e Unidade de Terapia Intensiva de um hospital de pequeno porte do recôncavo da Bahia, Brasil. Os dados foram coletados em março e abril de 2019, por meio da observação não participante, tendo como instrumento dois roteiros de observação. As variáveis descritivas foram analisadas por meio da distribuição de frequência absoluta e relativa. Resultados destacou-se os erros de técnica com observação da ocorrência de 60% de erros de técnica do preparo e 75% de erros de técnica de administração dos medicamentos intravenosos. Conclusão Tanto no preparo quanto na administração dos medicamentos intravenosos, foram identificados erros de técnica e de horário, apontando a necessidade de implementação de estratégias voltadas para a segurança do paciente.

Objetivo identificar errores en la preparación y administración de medicaciones intravenosas. Método estudio observacional y descriptivo, realizado con 694 dosis de medicaciones intravenosas realizadas por profesionales de enfermería en pacientes adultos en las Unidades de Emergencia, Internación y Cuidados Intensivos de un pequeño hospital en el recóncavo de Bahía, Brasil. Los datos fueron recolectados en los meses de marzo y abril de 2019, mediante observación no participante, utilizando dos guiones de observación como instrumento. Las variables descriptivas se analizaron mediante la distribución de frecuencia absoluta y relativa. Resultados se observaron errores técnicos, con ocurrencia del 60% de errores de técnica de preparación y 75% de errores de técnica de administración de fármacos intravenosos. Conclusión tanto en la preparación como en la administración de medicamentos por vía intravenosa se identificaron errores en la técnica y en el tiempo, señalando la necesidad de implementar estrategias orientadas a la seguridad del paciente.

Objective to identify errors in the preparation and administration of intravenous drugs. Method observational and descriptive study. 694 doses of intravenous medications performed by nursing professionals in adult patients were observed in the Emergency, Inpatient and Intensive Care Units of a small hospital in the recôncavo of Bahia, Brazil. Data were collected in March and April 2019, through non-participant observation, using two observation scripts as instruments. Descriptive variables were analyzed using the absolute and relative frequency distribution. Results the occurrence of 60% of errors in the preparation technique and 75% of errors in the technique of administering intravenous drugs was highlighted. Conclusion both in the preparation and administration of intravenous medications, errors in technique and time were identified, pointing out the need to implement strategies aimed at patient safety.

Estudio de la percepción de los profesionales implicados en el proceso de suministro de medicación a ancianos que viven en residencias desde una farmacia comunitaria / Study of the perception of the professionals involved in the process of administering medications to the elderly who live in residences from a community pharmacy

Introducción: la consulta a los profesionales implicados en el proceso de suministro de medicación a los centros sociosanitarios permite conocer su percepción sobre dicho proceso y las posibles mejoras que se puedan introducir en él, como la implantación de un protocolo que estandarice toda la cadena de suministro. Material y métodos: estudio observacional descriptivo realizado en dos residencias de ancianos con una muestra de 50 profesionales voluntarios, que respondieron de forma anónima a un cuestionario elaborado ad hoc para la investigación. Resultados: un 76 % da mucha importancia a la cadena de suministro de medicación al anciano. El 78 % vio relevante la implantación de un protocolo que regule el proceso. El 72 % destacó como muy importante la relación entre farmacia comunitaria y residencia. El 54 % opinó que la limitada legibilidad de lo escrito en la orden de prescripción produce errores. El 34 % señaló que nunca hay errores por confusión de horarios de administración, dosis o duración de tratamientos. El 58 % indicó que pocas veces hay errores relacionados con la transmisión de información. El 86 % opinó que nunca se producen errores por el envío de la orden de prescripción a la farmacia comunitaria. Conclusiones: la atención farmacéutica al anciano en centros sociosanitarios y la implantación de un protocolo que regule todo el proceso de suministro de medicación fueron consideradas muy importantes por la mayoría de los profesionales implicados en el proceso. El ambiente positivo de colaboración generado por la consulta ha llevado a plantear a los participantes el diseño de un protocolo

Background and aim: The query to the professionals involved in the process of supplying medication to the socio-health centers allows us to understand their perception of the process and the possible improvements that could be made to the supply chain, such as the implemen-tation of a protocol that standardizes the entire supply chain.Methods and results: A descriptive observational study conducted in two nursing homes with a sample of 50 volunteer professionals, who responded anonymously to a questionnaire prepared ad hoc for researchOutcomes: 76 % of respondants saw the importance in the medication supply chain to the elderly. 78 % saw the implementation of a protocol that regulates the process as relevant. 72 % highlighted the relationship between the Cummunity Pharmacy and residence as very important. 54 % thought that the limited readability of what was written in the prescription order produces errors. 34 % indicated there are never errors due to confusion of administration schedules, doses or duration of treatments. 58 % indicated there are rarely errors related to the transmission of information. 86 % thought errors do not occur in the proccess of sending the prescription order to the Community Pharmacy.Conclusions: Pharmaceutical care for the elderly in socio-health centers and the implementation of a protocol which regulates the entire medication supply process were considered very important by the majority of professionals involved in the process. The positive collaboration environment generated by the consultation has made think to the participants about the design of a protocol

Case Study: Using Electronic Medication Administration Record to Enhance Medication Safety and Improve Efficiency in Long-Term Care Facilities.

The electronic medication administration record (eMAR) has been used in hospitals and acute care facilities in Canada for over a decade. Unfortunately, the Canadian continuing care sector has been slow to adopt eMAR usage. Medication delivery in long-term care has traditionally been through paper-based orders and manual documentation in the paper medication administration record. The effectiveness of this manual system as it relates to medication incidents, patient safety and nursing efficiency is not well understood because most of the information is based on anecdotal evidence. Peer-reviewed scientific literature supports the premise that the eMAR, compared to the MAR, is more efficient, significantly reduces medication incidents, promotes patient safety and improves workflow efficiency. In April 2016, the Brenda Strafford Foundation committed to implementing the eMAR at each of our three long-term care facilities to improve medication delivery, reducing and eliminating medication incidents and evaluating the benefits of the electronic system. Under the direction of the clinical team, including nurses, physicians, pharmacists, and the software provider/vendor, an electronic system was developed and new processes for medication delivery were instituted within eight months of starting the project. Since the past year, the evaluation of the eMAR at the Brenda Strafford Foundation demonstrated a reduction in medication delivery time allowing for more time for direct care and a decrease in medication incidents, which directly affects resident health and safety. Nursing and the healthcare aides trained in medication management were surveyed and indicated that the eMAR provides a holistic view of the resident and provides important information readily available to improve the quality of resident care.

Safety Evaluation of Individual Pillboxes to Control Cross-Contamination in the Drug Circuit in Hospitals.

This study aims to evaluate the potential role of pillboxes used for the preparation and delivery of individual daily medical treatments in the drug circuit of the Military Instruction Hospital (France) as reservoirs of bacterial contaminants. Samples were obtained from 32 pillboxes after decontamination (T1), after preparation in the pharmacy (T2), after use in two different medical units (T3), and again after usual mechanical washing (T4). Qualitative (identification and antibiotic susceptibility) and quantitative (contamination rate and number of colony forming units-CFUs) bacteriological tests were performed. Susceptible and resistant strains of environmental saprophytes were identified. The pillbox contamination rate was relatively low at T1 (13%). It was significantly increased at T2 (63%, p = 0.001 vs. T1), again at T3 (88%, p < 0.05 vs. T2, p < 0.001 vs. T1), and finally decreased dramatically at T4 (31%, p < 0.001 vs. T3, p > 0.05 vs. T1). The number of CFUs was significantly increased at T2 compared with that of T1 (36.7 ± 13.4 and 5.36 ± 3.64, respectively, p < 0.001) and again at T3 (84.4 ± 19.4, p < 0.001 vs. T1 and T2) and was significantly reduced at T4 (7.0 ± 2.0 vs. T3, p < 0.001) to a level that was not significantly different from that at T1. So, the use of pillboxes to deliver individual medications to patients in the hospital is a potential risk factor for bacterial cross-contamination.